Jeffrey Moskowitz, MD
Procedural Dermatology · Oviedo, FLNPI 1558363952
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.7% of the total across 145 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 17.2% — the pattern of someone who eats at a lot of different presentations.
Across 145 payments — averaging $19.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$488
- Novartis$355
- Regeneron Healthcare Solutions, Inc.$288
- Sanofi$187
- Pfizer$180
- Amgen$132
- plus $1K from 23 others
What the payments were for
- Food & beverage$2,66294%
- Education$1796%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 22 | $488 |
| Novartis | 25 | $355 |
| Regeneron Healthcare Solutions, Inc. | 10 | $288 |
| Sanofi | 8 | $187 |
| Pfizer | 9 | $180 |
| Amgen | 6 | $132 |
| Johnson & Johnson | 4 | $130 |
| UCB, Inc. | 5 | $110 |
| Incyte Corporation | 6 | $109 |
| LEO Pharma Inc. | 5 | $96 |
| Galderma Laboratories, L.p. | 5 | $91 |
| E.r. Squibb & Sons, L.L.C. | 4 | $83 |
| Dermavant Sciences, Inc. | 4 | $78 |
| Arcutis Biotherapeutics, Inc. | 4 | $74 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $67 |
| Almirall LLC | 4 | $62 |
| Boehringer Ingelheim | 2 | $46 |
| Genentech USA, Inc. | 3 | $40 |
| Sun Pharmaceutical Industries Inc. | 2 | $38 |
| Sanofi-aventis U.S. LLC | 2 | $35 |
| Botanix SB Inc | 2 | $35 |
| Nabriva Therapeutics, PLC | 1 | $18 |
| Mayne Pharma Commercial LLC | 1 | $17 |
| Mylan Pharmaceuticals Inc. | 1 | $16 |
| Dermira, Inc. | 1 | $15 |
| Kerecis Limited | 2 | $15 |
| Lilly USA, LLC | 1 | $13 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $13 |
| VYNE Pharmaceuticals Inc. | 1 | $13 |
How this compares
$2,841 in reported general payments places this provider in the 60th percentile of 60 procedural dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 58 | $2,866 |
| Fluorouracil | 38 | $2,513 |
| Hydrocortisone | 61 | $1,224 |
| Metronidazole | 18 | $985 |
| Minocycline Hcl | 28 | $976 |
| Doxycycline Hyclate | 42 | $964 |
| Triamcinolone Acetonide | 92 | $801 |
| Betamethasone Dipropionate | 25 | $754 |
| Betamethasone Diprop AugmentedBetamethasone Dipropionate | 21 | $689 |
| Clindamycin Phosphate | 13 | $555 |
| Mupirocin | 83 | $533 |
| Cephalexin | 268 | $500 |
| Ketoconazole | 49 | $473 |
| Imiquimod | 12 | $367 |
| ValacyclovirValacyclovir Hcl | 23 | $361 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Oviedo
- Alicia NunezOviedo$2K
- Luis SoroFort Lauderdale$307K
- Laertes ManuelidisFort Myers$252K
- Michael ScannonTampa$218K
- Christopher OconnellCoral Gables$76K
- Dimitry PalceskiWinter Park$23K
- Samantha MarroneOrlando$22K
- Robert BrownOrange Park$22K
- Ileana Perez-QuintairosSouth Miami$16K
- Lawrence StrongWellington$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.